Talis Biomedical Corporation TLIS
$ 4.38
3.55%
Quarterly report 2024-Q2
added 08-19-2024
Country |
USA |
IPO year |
2021 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Brian Coe M.B.A. |
Employees in the company |
- |
Shares |
1.82 M |
Market Cap[1] |
$ 7.96 M |
EBITDA (LTM) |
$ -81.5 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.